Cingulate Ownership
| CING Stock | USD 7.70 1.21 18.64% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Cingulate | Build AI portfolio with Cingulate Stock |
Cingulate Stock Ownership Analysis
The company recorded a loss per share of 2.77. Cingulate had not issued any dividends in recent years. The entity had 1:12 split on the 9th of August 2024. Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficithyperactivity disorder. The company was founded in 2012 and is headquartered in Kansas City, Kansas. Cingulate operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people. For more info on Cingulate please contact PharmD PharmD at 913 942 2300 or go to https://www.cingulate.com.Besides selling stocks to institutional investors, Cingulate also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Cingulate's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Cingulate's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Cingulate Quarterly Liabilities And Stockholders Equity |
|
Cingulate Insider Trades History
Only 1.38% of Cingulate are currently held by insiders. Unlike Cingulate's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Cingulate's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Cingulate's insider trades
Cingulate Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Cingulate is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cingulate backward and forwards among themselves. Cingulate's institutional investor refers to the entity that pools money to purchase Cingulate's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Sbi Securities Co Ltd | 2025-06-30 | 251 | Advisor Group Holdings, Inc. | 2025-06-30 | 42.0 | Commonwealth Equity Services Inc | 2025-06-30 | 120.5 K | Vanguard Group Inc | 2025-06-30 | 35.4 K | Susquehanna International Group, Llp | 2025-06-30 | 33.2 K | Geode Capital Management, Llc | 2025-06-30 | 32.2 K | Virtu Financial Llc | 2025-06-30 | 13.4 K | Ubs Group Ag | 2025-06-30 | 12.6 K | Lpl Financial Corp | 2025-06-30 | 12.2 K | Xtx Topco Ltd | 2025-06-30 | 10.9 K | Bank Of America Corp | 2025-06-30 | 7.5 K |
Cingulate Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cingulate insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cingulate's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cingulate insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cingulate Outstanding Bonds
Cingulate issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cingulate uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cingulate bonds can be classified according to their maturity, which is the date when Cingulate has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US172441BF30 Corp BondUS172441BF30 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Cingulate Corporate Filings
8K | 6th of February 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 12th of January 2026 Other Reports | ViewVerify | |
F4 | 5th of January 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 5th of August 2025 Other Reports | ViewVerify |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cingulate. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Can Biotechnology industry sustain growth momentum? Does Cingulate have expansion opportunities? Factors like these will boost the valuation of Cingulate. Projected growth potential of Cingulate fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Cingulate demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Understanding Cingulate requires distinguishing between market price and book value, where the latter reflects Cingulate's accounting equity. The concept of intrinsic value - what Cingulate's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push Cingulate's price substantially above or below its fundamental value.
It's important to distinguish between Cingulate's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cingulate should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Cingulate's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.